Page last updated: 2024-10-18

dalteparin and Brain Diseases

dalteparin has been researched along with Brain Diseases in 1 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.

Research Excerpts

ExcerptRelevanceReference
"Forty-three major postoperative hemorrhages (1."2.71Risk of postoperative hemorrhage after intracranial surgery after early nadroparin administration: results of a prospective study. ( Beck, J; Gerlach, R; Raabe, A; Scheuer, T; Seifert, V; Woszczyk, A, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gerlach, R1
Scheuer, T1
Beck, J1
Woszczyk, A1
Seifert, V1
Raabe, A1

Trials

1 trial available for dalteparin and Brain Diseases

ArticleYear
Risk of postoperative hemorrhage after intracranial surgery after early nadroparin administration: results of a prospective study.
    Neurosurgery, 2003, Volume: 53, Issue:5

    Topics: Adult; Aged; Anticoagulants; Bandages; Brain Diseases; Drug Administration Schedule; Female; Humans;

2003